Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zenotech Laboratories Ltd

NSE: ZENOTECH · BSE: 532039 · Pharmaceuticals & Biotechnology · 11 announcements

Share price
₹41.85
Market cap
₹255.4 Cr
Revenue (annual)
₹43.61 Cr
Net profit (annual)
₹-1.07 Cr
P/E (TTM)
-101.5×Sector 47.4×
Promoter holding
68.84%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:25 IST BSE
Annual General Meeting

Zenotech Laboratories Annual General Meeting

Zenotech Laboratories Limited concluded its 37th Annual General Meeting. Shareholders approved the adoption of financial statements and re-appointment of Mr. Jignesh Anantray Goradia as Director.

17:33 IST BSE
Annual General Meeting

Zenotech Laboratories Annual General Meeting

Zenotech Laboratories Limited will hold its 37th Annual General Meeting on September 25, 2026, via video conferencing. The cut-off date for voting is September 18, 2026.

16:33 IST BSE
Board Meeting Date

Zenotech Laboratories Board Meeting Date

Zenotech Laboratories will hold a board meeting on July 28, 2026. The board will consider unaudited standalone financial results for the June 2026 quarter.

17:30 IST BSE
Other Announcement

Zenotech Laboratories Other Announcement

Zenotech Laboratories submitted its Annual Secretarial Compliance Report for financial year 2025-26. The report highlights governance adherence and specific non-compliance regarding subsidiary financial disclosures.

16:12 IST BSE
Financial Results

Zenotech Laboratories Financial Results

Zenotech Laboratories Ltd approved audited standalone financial results for the quarter and year ended March 31, 2026. The Board met on April 29, 2026, to review performance and the auditor's report. These results were prepared in accordance with Ind AS and Regulation 33 of SEBI Listing Regulations.

15:02 IST BSE
Debt & Borrowing

Zenotech Laboratories Debt & Borrowing

Zenotech Laboratories Limited confirmed it is not classified as a Large Corporate (LC) per SEBI's debt-raising framework. The company reported zero outstanding borrowings as of March 31, 2026. Consequently, mandatory initial disclosure requirements for large corporates do not apply.

09:37 IST BSE
Price Movement Clarification

Zenotech Laboratories Price Movement Clarification

Zenotech Laboratories Limited clarified to BSE that recent stock price movements are market-driven. The company confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, stating no material information or impending announcements have been withheld.